ResearcherSeoul National UniversityNo recent work listed
Young Hoon Kim
Matched on ORCID iD 0000-0001-5554-3828; OpenAlex author ID A5100345268. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2012: 2 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 3 papers
Papers 8
- Tumor resectability and response on CT following neoadjuvant therapy for pancreatic cancer: inter-observer agreement study. Last author DOI 10.1007/s00330-021-08494-5↗
- Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14102476↗
- Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Resection for Locally Advanced Pancreatic C… Co-author DOI 10.5009/gnl20312↗
- Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity. Co-author DOI 10.1016/j.ejca.2017.02.010↗
- Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer. Co-author DOI 10.1016/j.surg.2016.12.038↗
- Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival. Co-author DOI 10.1097/mpa.0b013e31825b6ab0↗
- Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.jvir.2012.01.080↗
- Pancreatic cancer surgery: the state of the art. First author DOI 10.2174/138945012800564185↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jong-Chan Lee · 5 shared papers, 2017–2022 · strength 0.65
- Paper Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal… DOI 10.3390/cancers14102476↗
- Paper Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Res… DOI 10.5009/gnl20312↗
- Paper Tumor resectability and response on CT following neoadjuvant therapy for pancreatic cancer: inter-observer agreement st… DOI 10.1007/s00330-021-08494-5↗
- Jin‐Hyeok Hwang · 5 shared papers, 2017–2022 · strength 0.65
- Paper Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal… DOI 10.3390/cancers14102476↗
- Paper Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Res… DOI 10.5009/gnl20312↗
- Paper Tumor resectability and response on CT following neoadjuvant therapy for pancreatic cancer: inter-observer agreement st… DOI 10.1007/s00330-021-08494-5↗
- Jaihwan Kim · 5 shared papers, 2017–2022 · strength 0.65
- Paper Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal… DOI 10.3390/cancers14102476↗
- Paper Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Res… DOI 10.5009/gnl20312↗
- Paper Tumor resectability and response on CT following neoadjuvant therapy for pancreatic cancer: inter-observer agreement st… DOI 10.1007/s00330-021-08494-5↗
- Yoo‐Seok Yoon · 2 shared papers, 2017–2022 · strength 0.23
- Ho‐Seong Han · 2 shared papers, 2017–2022 · strength 0.23
- Dong Woo Shin · 1 shared paper, 2022 · strength 0.19
- Soomin Ahn · 1 shared paper, 2022 · strength 0.16
- Haeryoung Kim · 1 shared paper, 2022 · strength 0.16
- Hae Young Kim · 1 shared paper, 2022 · strength 0.16
- Hyoung Woo Kim · 2 shared papers, 2017 · strength 0.14
- Paper Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative rel… DOI 10.1016/j.ejca.2017.02.010↗
- Paper Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer. DOI 10.1016/j.surg.2016.12.038↗
- Song Cheol Kim · 3 shared papers, 2012–2013 · strength 0.12
- Paper Pancreatic cancer surgery: the state of the art. DOI 10.2174/138945012800564185↗
- Paper Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with pa… DOI 10.1097/mpa.0b013e31825b6ab0↗
- Paper Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma. DOI 10.1016/j.jvir.2012.01.080↗
- Jin Won Kim · 1 shared paper, 2017 · strength 0.07
- Young Ju Lee · 1 shared paper, 2012 · strength 0.04
- Ki Byung Song · 1 shared paper, 2013 · strength 0.04
- Sang Hyun Shin · 1 shared paper, 2013 · strength 0.04
- Seung‐Mo Hong · 1 shared paper, 2013 · strength 0.04
- Youngjoo Lee · 1 shared paper, 2013 · strength 0.04
- Jae Berm Park · 1 shared paper, 2012 · strength 0.03
- Tae Won Kim · 1 shared paper, 2012 · strength 0.03
- Duck Jong Han · 1 shared paper, 2012 · strength 0.03
- Pyo Nyun Kim · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.